Viser 1 - 50 av 157 resultater
Tid Selskap Tittel Sektor Kategori
07 May 2026
07:00 CEST
ZELLUNA Zelluna ASA: First Quarter 2026 results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
07 May 2026
07:00 CEST
ZELLUNA Zelluna ASA: Første kvartal 2026 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
06 May 2026
23:18 CEST
ZELLUNA Zelluna ASA aktiverer det første kliniske senteret for ZIMA-101studien, og markerer dermed oppstart av klinisk gjennomføring 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
06 May 2026
23:18 CEST
ZELLUNA Zelluna ASA activates first clinical site for ZIMA-101, marking entry into clinical execution 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 May 2026
17:58 CEST
ZELLUNA Zelluna ASA: Invitation to First Quarter 2026 results webcast Presentation (corrected time) 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 May 2026
15:19 CEST
ZELLUNA Zelluna ASA: Invitation to First Quarter 2026 results webcast Presentation 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
23 Apr 2026
09:37 CEST
ZELLUNA Zelluna ASA - Annual General Meeting held on April 23, 2026 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
08 Apr 2026
11:25 CEST
ZELLUNA Zelluna ASA - Disclosure of voting rights of Annual General Meeting 20103010 Biotechnology Major shareholding notifications
27 Mar 2026
10:01 CET
ZELLUNA Zelluna ASA - Mandatory notification of trade 20103010 Biotechnology Mandatory notification of trade primary insiders
26 Mar 2026
15:28 CET
ZELLUNA Zelluna to host Capital Markets Update 2026 20103010 Biotechnology Non-regulatory press releases
26 Mar 2026
08:57 CET
ZELLUNA Zelluna ASA [ZLNA]: Notice of Annual General Meeting on 23 April 2026 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
25 Mar 2026
07:00 CET
ZELLUNA Zelluna ASA [ZLNA]: Annual Report 2025 20103010 Biotechnology Annual financial and audit Reports
09 Mar 2026
08:00 CET
ZELLUNA Zelluna inngår samarbeid med Etcembly for AI-drevet TCR-utvikling 20103010 Biotechnology Ikke-informasjonspliktige pressemeldinger
09 Mar 2026
08:00 CET
ZELLUNA Zelluna announces collaboration with Etcembly for AI-enabled TCR engineering 20103010 Biotechnology Non-regulatory press releases
20 Feb 2026
14:30 CET
ZELLUNA Zelluna mottar UK MHRA og etisk godkjenning for oppstart av ZIMA-101 første-i-menneske klinisk studie 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
20 Feb 2026
14:30 CET
ZELLUNA Zelluna Receives UK MHRA and Ethics Approval to Initiate ZIMA-101 First-in-Human Clinical Trial 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
12 Feb 2026
07:00 CET
ZELLUNA Zelluna ASA: Fjerde kvartal 2025 - Viktig regulatorisk milepæl oppnådd med CTA-innlevering 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
12 Feb 2026
07:00 CET
ZELLUNA Zelluna ASA: Fourth Quarter 2025 - Key regulatory milestone achieved with CTA Submission 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
11 Feb 2026
08:00 CET
ZELLUNA Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial 20103010 Biotechnology Non-regulatory press releases
11 Feb 2026
08:00 CET
ZELLUNA Zelluna inngår avtale med Medpace om første kliniske studie - pasientdata ventes fra medio 2026 20103010 Biotechnology Ikke-informasjonspliktige pressemeldinger
05 Feb 2026
13:30 CET
ZELLUNA Zelluna ASA - Grant of Share Options 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
05 Feb 2026
09:30 CET
ZELLUNA Zelluna ASA: Invitation to Fourth Quarter 2025 Results Webcast Presentation 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
03 Feb 2026
08:00 CET
ZELLUNA Zelluna utnevner Emilie Gauthy til Chief Technology Officer 20103010 Biotechnology Ikke-informasjonspliktige pressemeldinger
03 Feb 2026
08:00 CET
ZELLUNA Zelluna promotes Emilie Gauthy to Chief Technology Officer 20103010 Biotechnology Non-regulatory press releases
15 Jan 2026
12:22 CET
ZELLUNA Zelluna ASA: Approval and publication of prospectus 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
17 Dec 2025
17:26 CET
ZELLUNA Zelluna har nådd en viktig milepæl og innleverer søknad om klinisk studie i Storbritannia for første studie på mennesker av ZI-MA4-1 (ZIMA-101), verdens første MAGE-A4-rettede TCR-NK celleterapi for solide kreftformer. 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
17 Dec 2025
17:26 CET
ZELLUNA Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World's First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
16 Dec 2025
12:36 CET
ZELLUNA Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World's First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours 20103010 Biotechnology Non-regulatory press releases
12 Dec 2025
13:02 CET
ZELLUNA Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
09 Dec 2025
09:36 CET
ZELLUNA Zelluna ASA: Cancellation of subsequent repair offering 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
09 Dec 2025
08:22 CET
ZELLUNA Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
08 Dec 2025
18:36 CET
ZELLUNA Zelluna ASA - Mandatory notification of trade 20103010 Biotechnology Major shareholding notifications
08 Dec 2025
13:52 CET
ZELLUNA Zelluna ASA: New share capital registered 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
28 Nov 2025
07:50 CET
ZELLUNA Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial Officer 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
27 Nov 2025
08:35 CET
ZELLUNA Zelluna ASA: Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
25 Nov 2025
16:05 CET
ZELLUNA Zelluna ASA: Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
25 Nov 2025
12:09 CET
ZELLUNA ZELLUNA ASA: DISCLOSURE OF LARGE SHAREHOLDING 20103010 Biotechnology Major shareholding notifications
25 Nov 2025
11:32 CET
ZELLUNA Zelluna ASA - Extraordinary General Meeting held on November 25, 2025 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
17 Nov 2025
10:33 CET
ZELLUNA Zelluna ASA: New share capital registered 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 Nov 2025
13:04 CET
ZELLUNA Zelluna ASA: Notice of extraordinary general meeting on 25 November 2025 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 Nov 2025
09:10 CET
ZELLUNA Zelluna ASA: Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
04 Nov 2025
08:28 CET
ZELLUNA Zelluna ASA: Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
04 Nov 2025
07:29 CET
ZELLUNA Zelluna ASA: Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
04 Nov 2025
07:00 CET
ZELLUNA Zelluna ASA - Ex. date 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 Nov 2025
00:58 CET
ZELLUNA Zelluna ASA - Key information relating to subsequent offering 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 Nov 2025
00:35 CET
ZELLUNA Zelluna ASA - Mandatory notification of trade 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
03 Nov 2025
23:52 CET
ZELLUNA Zelluna ASA - Successful private placement and retail offering 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
03 Nov 2025
16:47 CET
ZELLUNA Zelluna ASA - Contemplates private placement 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
03 Nov 2025
16:39 CET
ZELLUNA Zelluna ASA Reports Third Quarter 2025 Financial Results and Provides General Business Update 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
09 Oct 2025
07:58 CEST
ZELLUNA Zelluna Receives Positive MHRA Feedback and Strengthens UK Clinical Strategy for ZI-MA4-1 Paving the Way for First-in-Human Trials in the UK 20103010 Biotechnology Inside information